학술논문
Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
이용수 7
- 영문명
- Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
- 발행기관
- 대한방사선종양학회
- 저자명
- Ben Man Fei Cheung
- 간행물 정보
- 『대한방사선종양학회지』제42권 제1호, 4~16쪽, 전체 13쪽
- 주제분류
- 의약학 > 종양학
- 파일형태
- 발행일자
- 2024.03.30
4,360원
구매일시로부터 72시간 이내에 다운로드 가능합니다.
이 학술논문 정보는 (주)교보문고와 각 발행기관 사이에 저작물 이용 계약이 체결된 것으로, 교보문고를 통해 제공되고 있습니다.
국문 초록
영문 초록
Purpose: Stereotactic body radiotherapy (SBRT) has been widely utilized for curative treatment of early-stage non-small cell lung cancer (NSCLC). It has achieved good local control rate comparable to surgery. Currently, no standard risk model exists for SBRT outcome or complication prediction. Radiomics has the potential to improve clinical outcome prognostication. Here, we reviewed the current literature on the radiomic analyses of thoracic SBRT through the use of radiomic quality score (RQS).
Materials and Methods: Literature search was conducted on PubMed and Embase to retrieve radiomics studies on SBRT for early NSCLC. The literature search included studies up to June 2021. Only full papers published in peer reviewed journals were included. Studies that included metastatic lung cancers or non-lung cancers were excluded. Two independent investigators evaluated each study using the RQS and resolved discrepancies through discussion.
Results: A total number of 25 studies were analysed. The mean RQS was 7.76 of a maximum score of 36. This corresponds to 21.56% of the maximum score. Lack of feature reduction strategies, external validation and open data sharing were identified as key limitations of the reviewed studies. Meanwhile, various common radiomic signatures across different studies such as gray level co-occurrence matrix Homogeneity and energy have been identified. Multiple robust radiomic models have also been reviewed that may improve outcome or complication prediction.
Conclusion: Radiomics in thoracic SBRT has a very promising future as a prognostication tool. However, larger multicenter prospective studies are required to confirm radiomic signatures. Improvement in future study methodologies can also facilitate its wider application.
목차
Introduction
Materials and Methods
Results
Discussion and Conclusion
Statement of Ethics
Conflict of Interest
Funding
Author Contributions
Data Availability Statement
Supplementary Materials
References
해당간행물 수록 논문
- Radiomics in stereotactic body radiotherapy for non-small cell lung cancer: a systematic review and radiomic quality score study
- Hypofractionated radiation therapy for head and neck cancers in the era of intensity-modulated radiation therapy
- Comparison of radiotherapy techniques in patients with thymic epithelial tumor who underwent postoperative radiotherapy
- Long-term toxicities after allogeneic hematopoietic stem cell transplantation with or without total body irradiation: a population-based study in Korea
- Interobserver delineation variability of computed tomography-based radiomic features of the parotid gland
- Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
- Pulsed low-dose rate radiotherapy for recurrent bone sarcomas: case reports and brief review
- Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation
- Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
- Treatment of Fanconi anemia patient with synchronous esophageal and tongue cancer in COVID-19 era: a case report
참고문헌
관련논문
의약학 > 종양학분야 BEST
- 식도암에서 근치적 절제술 후 방사선치료의 역할
- Impact of adaptive radiotherapy on survival in locally advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy
- 노인 두경부암 환자의 생존에 있어 노쇠의 의의
의약학 > 종양학분야 NEW
- 대한두경부종양학회지 제40권 제2호 목차
- 볼지방덩이의 일측성 지방종: 증례 보고
- 소아 이하선 악성 종양의 국내 발생 추이 및 이하선 수술에 대한 단일 기관에서의 경험에 대한 후향적 분석 연구
최근 이용한 논문
교보eBook 첫 방문을 환영 합니다!
신규가입 혜택 지급이 완료 되었습니다.
바로 사용 가능한 교보e캐시 1,000원 (유효기간 7일)
지금 바로 교보eBook의 다양한 콘텐츠를 이용해 보세요!